Not logged in...
About USC Norris
Research
Patient Care
CISO
Search Trials
FAQ - Trials
Contact Us - Trials
Membership
Education
Shared Resources
Support USC Norris
Outreach
Login/Logout
Contact USC Norris
Support Us
Donate
Menu
USC Norris
»
Clinical Trials
Trial 0C-13-1
An Open-Label, Parallel-Group, Multi-Center Phase I Study to Investigate the Pharmacokinetics of NKTR-102 for Injection (Etirinotecan Pegol) in Patients with Advanced or Metastatic Solid Tumors and Hepatic Impairment.
Type:
Treatment
Phase:
Phase I
Status:
Not Open (Closed)
Treatments:
Chemotherapy: Systemic
Randomized:
No
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:
Anthony El-Khoueiry, M.D.
Other Trial Staff:
Anayansi Miloud, D.M., Xiomara Menendez, R.N., Jubilee Acap, R.N., Khatchik Karakozian, D.M., Molly Oswald, R.N., Sherine Elsayegh, D.M.
Staff may
log in
to see study documents.
Click here to see trial eligibility criteria and further details at ClinicalTrials.gov
For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or
clinical.trials@med.usc.edu
.
To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.